Streetbeat News

Products Services

AAPL

AMZN

GLD

GOOG

META

MSFT

NVDA

QQQ

SLV

SPY

TSLA

USO

The stock market is experiencing a consolidation phase with mixed money flows in major tech stocks and ETFs. Despite a weak Treasury auction, the market saw a strong oversold bounce driven by short covering. Fed officials are not in favor of an emergency rate cut, and Bitcoin has surged above $60,000. Investors are advised to maintain a protection band and consider tactical positions in bonds.

Portfolio Pulse from The Arora Report

August 09, 2024 | 4:01 pm

RUM

Rumble CEO Chris Pavlovski announced on X that the company has launched Rumble Premium and plans to expand the offering in the coming months.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 3:58 pm

CAT

Deep-pocketed investors are showing significant interest in Caterpillar (NYSE:CAT) options, with a mix of bullish and bearish sentiments. The options activity suggests a focus on a price range between $270 and $370. Analysts have mixed ratings on CAT, with target prices ranging from $285 to $399.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 3:46 pm

SPRY

ARS Pharmaceuticals shares are trading higher following the FDA's approval of neffy nasal spray for the emergency treatment of anaphylaxis and allergic reactions (Type I).

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 3:45 pm

CBWTF

MEDIF

VEXTF

Vext Science, Auxly Cannabis Group, and MediPharm Labs are set to release their Q2 2024 financial results in mid-August. Vext Science is highlighted for its significant growth potential, especially in the Ohio market. Auxly has shown record-breaking Q1 results and significant debt conversion into equity. MediPharm has entered a licensing agreement for advanced cannabis products and reported a 67% revenue increase in Q1 2024.

Portfolio Pulse from Jelena Martinovic

August 09, 2024 | 3:37 pm

TLLTF

TILT Holdings Inc. reported a revenue decline in Q2 2024 due to challenges in its Jupiter hardware business, but saw improvements in gross profit and cash flow from operations. The company is optimistic about growth opportunities in Ohio's cannabis market and has expanded its brand portfolio in Pennsylvania.

Portfolio Pulse from Patricio Liddle

August 09, 2024 | 3:31 pm

PBR

Petrobras has received an environmental license to increase oil production at the Buzios field. The company plans to lower its capital expenditures (Capex) in 2024 due to strategic changes in exploration and production (E&P) and delays in refining investments. Petrobras is also analyzing four potential mergers and acquisitions (M&A) in the renewables sector. The interim E&P director mentioned efforts to start the FPSO Almirante Tamandare early at the Buzios field. Despite lower Capex in 2024, the CFO stated that next year's Capex will be higher than this year's.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 3:30 pm

PBR

Petrobras' CEO emphasized the need to continue exploring the Pelotas Basin and acknowledged investor demands for dividends. The CFO announced that the FPSO vessel Almirante Tamandare is set to start production in 2025. A tax deal with the government was beneficial for Petrobras, and the capital reserve was used to pay dividends, which would have been difficult without the reserve.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 3:28 pm

SPRY

The FDA has approved neffy, the first nasal spray for the treatment of anaphylaxis, which is an emergency treatment for severe allergic reactions (Type I).

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 3:25 pm

BURU

Nuburu has been awarded an $849,989 NASA SBIR Phase II contract for a blue laser planetary and lunar management of electrical power project, with a completion date of August 7, 2026.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 3:20 pm